Clinical Trial Update: Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous dendritic cell and tumor lysate immunization in Stage III/IV malignant melanoma of the skin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma of the Skin

Snippet

Sponsor: University of Chile | Conditions: Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin | Phase 1, Phase 2 | Status: COMPLETED